PER 2.35% 8.3¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-15

  1. 340 Posts.
    lightbulb Created with Sketch. 126
    At long last! After 3.5 years since last patient dosed in the phase IIA, finally ATL1102 is being progressed.

    Wonderful news for the company and for boys suffering from DMD.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
-0.002(2.35%)
Mkt cap ! $74.82M
Open High Low Value Volume
8.3¢ 8.4¢ 8.3¢ $33.95K 407.4K

Buyers (Bids)

No. Vol. Price($)
2 12164 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 1366 1
View Market Depth
Last trade - 15.57pm 03/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.